Ms. Michelle G Vasilakis, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Southgate Rd, Loundonville, NY 12211 Phone: 518-785-6607 |
News Archive
A new study reports the approval of a new CRISPR-based coronavirus test that is both sensitive and rapid and intended to help reduce the time required to test symptomatic or potentially contagious cases.
The Washington Post: "Democrats had little time to savor their weekend Senate health-care victory, as two of the lawmakers who voted to move the debate forward Saturday night indicated Sunday that they will not vote to pass the package if it includes a government-run insurance program."
Further to a Letter of Intent previously reported, Genesis Bioventures today announced that it has entered into a binding agreement with Efoora Inc. and Prion Developmental Laboratories, Inc. to buy all of Efoora's majority interest shares owned or pledged in PDL thereby gaining controlling interest of PDL. A Form 8-K has been filed with the SEC in this regard. Prior to the Agreement, GBI had one-third equity interest in PDL.
Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that the first patient has been treated in an international, multi-center study of the Company's Cartiva Synthetic Cartilage Implant (SCI). The study aims to determine the effectiveness of Cartiva SCI in comparison to arthrodesis (joint fusion), the current standard of care, for reducing the debilitating pain associated with osteoarthritis of the first metatarsophalangeal (MTP) joint.
› Verified 8 days ago